Yue Liu

Dr. Yue Liu is the founder and president of Ab Studio Inc, and founder and CEO of Ab Therapeutics Inc. She has extensive experience at the frontier of cancer biology, neurodegenerative disease and regenerative medicine intersect, proven experience and expertise in pioneering development of new therapeutic antibodies. She is the project leader in antibody discovery, engineering, humanization and optimization. She has extensive experience in phage display, mammalian display and B cell cloning, and has deep expertise in molecular modeling and computer aided design. She also has hands on experience in high throughput antibody/protein production and characterization, and extensive experience in writing scientific report to support patent application and IND filing.